Product Description
Anti-mouse CD8 clone choice is critical when mouse MHC I tetramers, as some clones, including 53-6.7, lead to high background staining of all CD8+ T cells, rather than the antigen-specific ones. For best results, clone KT15 in FITC (MBL-K0227-4) is recommended. Additional information can be found in the datasheet that accompanies mouse class I tetramers, as well as the following reference containing a protocol for performing a cross titration series for optimization: Current Protocols in Immunology, MHC-Peptide tetramers to Visualize Antigen-Specific T Cells, Section 17.3.23-24, Supplement 54| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | APC |
| Immunogen | OVA |
| Peptide Sequence | SIINFEKL |
| Class | Class I |
| Sequence Location | 257-264 |
| MHC Allele | H-2Kb |
| Documents & Links for H-2Kb OVA Tetramer-SIINFEKL-APC | |
| Datasheet | H-2Kb OVA Tetramer-SIINFEKL-APC Datasheet |
| Documents & Links for H-2Kb OVA Tetramer-SIINFEKL-APC | |
| Datasheet | H-2Kb OVA Tetramer-SIINFEKL-APC Datasheet |
| Citations for H-2Kb OVA Tetramer-SIINFEKL-APC – 1 Found |
| Li, Xia; Wang, Xiupeng; Ito, Atsuo; Tsuji, Noriko M. A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity. Nature Communications. 2020;11(1):3858. PubMed |